Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 25;14(5):e01206-23. doi: 10.1128/mbio.01206-23

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Seow et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

PMC Copyright notice

Fig 6 — mAb neutralization against more recent VOCs including BA.2.75.2, XBB/XBB.1.5, and BQ.1.1. Neutralization by (A) plasma from individuals vaccinated with two doses of BNT162b2 and were subsequently Delta infected (ID₅₀), (B) mAbs from Delta BTI donors (IC₅₀), and (C) mAbs from BA.1 BTI donor (IC₅₀). Sera were collected 15–35 days post-infection. Additional plasma/sera samples from double vaccinated and BA.1-infected individuals were not available. Horizontal line represents geometric mean IC₅₀ (for mAbs) or geometric mean titers (sera). (D) Neutralization breadth and potency broken down by RBD competition group. Data for each mAb are linked. Dotted line represents the highest concentration of mAb or lowest dilution of sera tested (related to Fig. S7).